{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:01:28Z","timestamp":1785848488853,"version":"3.56.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004012","name":"Jane and Aatos Erkko Fundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004155","name":"Magnus Ehrnrooth Fundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010711","name":"Sy\u00f6p\u00e4s\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015735","name":"HiLIFE","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Suomen Akatemia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Oncolytics"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.omto.2022.04.002","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T13:15:15Z","timestamp":1650374115000},"page":"137-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7166-3018","authenticated-orcid":false,"given":"Manlio","family":"Fusciello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkko","family":"Yl\u00f6sm\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4012-4310","authenticated-orcid":false,"given":"Sara","family":"Feola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7560-8342","authenticated-orcid":false,"given":"Arttu","family":"Uoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8179-9699","authenticated-orcid":false,"given":"Beatriz","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karri","family":"Aalto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4678-7382","authenticated-orcid":false,"given":"Firas","family":"Hamdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6577-2691","authenticated-orcid":false,"given":"Jacopo","family":"Chiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9074-9450","authenticated-orcid":false,"given":"Tapani","family":"Viitala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4901-3796","authenticated-orcid":false,"given":"Vincenzo","family":"Cerullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omto.2022.04.002_bib1","doi-asserted-by":"crossref","first-page":"e10375","DOI":"10.15252\/emmm.201910375","article-title":"Repurposing the yellow fever vaccine for intratumoral immunotherapy","volume":"12","author":"Aznar","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omto.2022.04.002_bib2","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1073\/pnas.1904022116","article-title":"Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer","volume":"117","author":"Newman","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U\u00a0S\u00a0A"},{"key":"10.1016\/j.omto.2022.04.002_bib3","doi-asserted-by":"crossref","first-page":"eaat5025","DOI":"10.1126\/scitranslmed.aat5025","article-title":"Repurposing rotavirus vaccines for intratumoral immunotherapy can overcome resistance to immune checkpoint blockade","volume":"11","author":"Shekarian","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omto.2022.04.002_bib4","doi-asserted-by":"crossref","first-page":"e000443","DOI":"10.1136\/jitc-2019-000443","article-title":"Repurposing infectious disease vaccines for intratumoral immunotherapy","volume":"8","author":"Melero","year":"2020","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.omto.2022.04.002_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-020-00213-8","article-title":"Overcoming cancer therapeutic bottleneck by drug repurposing","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.omto.2022.04.002_bib6","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1158\/1078-0432.CCR-13-0143","article-title":"CTLA-4 and PD-1\/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients","volume":"19","author":"Ott","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omto.2022.04.002_bib7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ccell.2020.03.017","article-title":"Acquired resistance to immune checkpoint inhibitors","volume":"37","author":"Schoenfeld","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omto.2022.04.002_bib8","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/cncr.24951","article-title":"Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival","volume":"116","author":"Ku","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.omto.2022.04.002_bib9","doi-asserted-by":"crossref","first-page":"16723","DOI":"10.1073\/pnas.1110814108","article-title":"Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab","volume":"108","author":"Yuan","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U\u00a0S\u00a0A"},{"key":"10.1016\/j.omto.2022.04.002_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/bjc.2017.434","article-title":"Mechanisms of resistance to immune checkpoint inhibitors","volume":"118","author":"Jenkins","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.omto.2022.04.002_bib11","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.ymthe.2018.06.008","article-title":"Personalized cancer vaccine platform for clinically relevant oncolytic enveloped viruses","volume":"26","author":"Yl\u00f6sm\u00e4ki","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omto.2022.04.002_bib12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0065-3233(03)01010-6","article-title":"Enveloped viruses","volume":"64","author":"Kuhn","year":"2003","journal-title":"Adv. Protein Chem."},{"key":"10.1016\/j.omto.2022.04.002_bib13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0092-8674(88)91043-4","article-title":"Introduction of soluble protein into the class I pathway of antigen processing and presentation","volume":"54","author":"Moore","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.omto.2022.04.002_bib14","first-page":"291","article-title":"H-2Kb transfection of B16 melanoma cells results in reduced tumourigenicity and metastatic competence","volume":"16","author":"Porgador","year":"1989","journal-title":"J.\u00a0Immunogenet."},{"key":"10.1016\/j.omto.2022.04.002_bib15","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.2174\/138920112800958896","article-title":"Attenuated oncolytic measles virus strains as cancer therapeutics","volume":"13","author":"Msaouel","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.omto.2022.04.002_bib16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/07357907.2018.1434539","article-title":"Combination of vaccine-strain measles and mumps viruses enhances oncolytic activity against human solid malignancies","volume":"36","author":"Son","year":"2018","journal-title":"Cancer Invest."},{"key":"10.1016\/j.omto.2022.04.002_bib17","doi-asserted-by":"crossref","first-page":"e1457596","DOI":"10.1080\/2162402X.2018.1457596","article-title":"Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors","volume":"7","author":"Feola","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.omto.2022.04.002_bib18","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1080\/21645515.2020.1773141","article-title":"Vaccine repurposing approach for preventing COVID 19: can MMR vaccines reduce morbidity and mortality?","volume":"16","author":"Anbarasu","year":"2020","journal-title":"Hum.\u00a0Vaccin. Immunother."},{"key":"10.1016\/j.omto.2022.04.002_bib19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12859-021-04045-3","article-title":"In silico comparative study of SARS-CoV-2 proteins and antigenic proteins in BCG, OPV, MMR and other vaccines: evidence of a possible putative protective effect","volume":"22","author":"Haddad-Boubaker","year":"2021","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.omto.2022.04.002_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03447-20","article-title":"MMR vaccine and COVID-19: measles protein homology may contribute to cross-reactivity or to complement activation protection","volume":"12","author":"Marakasova","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.omto.2022.04.002_bib21","article-title":"Protective heterologous T\u00a0cell immunity in COVID-19 induced by MMR and Tdap vaccine antigens","author":"Mysore","year":"2021","journal-title":"bioRxiv"}],"container-title":["Molecular Therapy - Oncolytics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770522000547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770522000547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:23:35Z","timestamp":1762496615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2372770522000547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":21,"alternative-id":["S2372770522000547"],"URL":"https:\/\/doi.org\/10.1016\/j.omto.2022.04.002","relation":{},"ISSN":["2372-7705"],"issn-type":[{"value":"2372-7705","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Oncolytics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omto.2022.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}]}}